tradingkey.logo

Danaher Corp

DHR
查看詳細走勢圖
226.330USD
0.000
收盤 12/15, 16:00美東報價延遲15分鐘
159.86B總市值
46.35本益比TTM

Danaher Corp

226.330
0.000
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

0.00%

5天

+0.82%

1月

+2.31%

6月

+12.79%

今年開始到現在

-1.40%

1年

-3.64%

查看詳細走勢圖

TradingKey Danaher Corp股票評分

單位: USD 更新時間: 2025-12-12

操作建議

Danaher Corp當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名55/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價256.10。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Danaher Corp評分

相關信息

行業排名
55 / 208
全市場排名
140 / 4592
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 27 分析師
買入
評級
256.100
目標均價
+14.09%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Danaher Corp亮點

亮點風險
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
高分紅
公司屬於高分紅公司,最新股息支付率20.13%
穩定分紅
公司5年內持續分紅,最新股息支付率20.13%
估值高估
公司最新PE估值46.35,處於3年歷史高位
機構加倉
最新機構持股600.67M股,環比增加0.00%
大衛赫羅持倉
明星投資者大衛赫羅持倉,最新持倉3.32K股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.06

Danaher Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Danaher Corp簡介

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
公司代碼DHR
公司Danaher Corp
CEOBlair (Rainer M)
網址https://www.danaher.com/

常見問題

Danaher Corp(DHR)的當前股價是多少?

Danaher Corp(DHR)的當前股價是 226.330。

Danaher Corp 的股票代碼是什麼?

Danaher Corp的股票代碼是DHR。

Danaher Corp股票的52週最高點是多少?

Danaher Corp股票的52週最高點是258.230。

Danaher Corp股票的52週最低點是多少?

Danaher Corp股票的52週最低點是171.000。

Danaher Corp的市值是多少?

Danaher Corp的市值是159.86B。

Danaher Corp的淨利潤是多少?

Danaher Corp的淨利潤為3.90B。

現在Danaher Corp(DHR)的股票是買入、持有還是賣出?

根據分析師評級,Danaher Corp(DHR)的總體評級為買入,目標價格為256.100。

Danaher Corp(DHR)股票的每股收益(EPS TTM)是多少

Danaher Corp(DHR)股票的每股收益(EPS TTM)是4.883。
KeyAI